They found that for FDA approved GLP-1s for weight loss, liraglutide (Saxenda) and semaglutide (Wegovy), the percent of side effects reported was as follows: Nausea: 42.2% Diarrhea: 21.9% Vomiting: also 21.9% Constipation: 8.4% They report that although the incidence of side effects were similar among medications, semaglutide had the greatest risk of nausea, diarrhea, and vomiting, whereas liraglutide had the greatest risk of upper abdominal pain
It's best to talk to a doctor or dietitian before making big changes to your diet or health routine
Chapter 13
You do not need special training
In both SLD-fed and HFHC-fed Dpp4 / mice, lack of Dpp4 did not affect HDL, LDL, or total cholesterol levels in plasma (Figure 3, EG)
Metabolic/bariatric surgery also modifies bone microarchitecture and strength, and increases the risk of fracture [10,11,12]